Non-viral COVID-19 vaccine delivery systems
The novel corona virus termed severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) has spread throughout the globe at a formidable speed, causing tens of millions of …
CoV-2) has spread throughout the globe at a formidable speed, causing tens of millions of …
COVID-19 vaccines:“Warp Speed” needs mind melds, not warped minds
JP Moore, PJ Klasse - Journal of virology, 2020 - Am Soc Microbiol
In this review, we address issues that relate to the rapid “Warp Speed” development of
vaccines to counter the COVID-19 pandemic. We review the antibody response that is …
vaccines to counter the COVID-19 pandemic. We review the antibody response that is …
The immunodominant and neutralization linear epitopes for SARS-CoV-2
S Lu, X Xie, L Zhao, B Wang, J Zhu, T Yang, G Yang… - Cell reports, 2021 - cell.com
Although vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
are under development, the antigen epitopes on the virus and their immunogenicity are …
are under development, the antigen epitopes on the virus and their immunogenicity are …
Identification of immunodominant linear epitopes from SARS-CoV-2 patient plasma
A novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) is the source of a
current pandemic (COVID-19) with devastating consequences in public health and …
current pandemic (COVID-19) with devastating consequences in public health and …
SARS-CoV-2 proteome-wide analysis revealed significant epitope signatures in COVID-19 patients
T Schwarz, K Heiss, Y Mahendran, F Casilag… - Frontiers in …, 2021 - frontiersin.org
The WHO declared the COVID-19 outbreak a public health emergency of international
concern. The causative agent of this acute respiratory disease is a newly emerged …
concern. The causative agent of this acute respiratory disease is a newly emerged …
Peptide microarray‐based analysis of antibody responses to SARS‐CoV‐2 identifies unique epitopes with potential for diagnostic test development
P Holenya, PJ Lange, U Reimer… - European Journal of …, 2021 - Wiley Online Library
Humoral immunity to the Severe Adult Respiratory Syndrome (SARS) Coronavirus (CoV)‐2
is not fully understood yet but is a crucial factor of immune protection. The possibility of …
is not fully understood yet but is a crucial factor of immune protection. The possibility of …
ORFeome phage display reveals a major immunogenic epitope on the S2 subdomain of SARS-CoV-2 spike protein
R Ballmann, SK Hotop, F Bertoglio, S Steinke… - Viruses, 2022 - mdpi.com
The development of antibody therapies against SARS-CoV-2 remains a challenging task
during the ongoing COVID-19 pandemic. All approved therapeutic antibodies are directed …
during the ongoing COVID-19 pandemic. All approved therapeutic antibodies are directed …
Engineering materials and devices for the prevention, diagnosis, and treatment of COVID-19 and infectious diseases
Following the global spread of COVID-19, scientists and engineers have adapted
technologies and developed new tools to aid in the fight against COVID-19. This review …
technologies and developed new tools to aid in the fight against COVID-19. This review …
Prospects of replication-deficient adenovirus based vaccine development against SARS-CoV-2
M Garofalo, M Staniszewska, S Salmaso, P Caliceti… - Vaccines, 2020 - mdpi.com
The current appearance of the new SARS coronavirus 2 (SARS-CoV-2) and it quickly
spreading across the world poses a global health emergency. The serious outbreak position …
spreading across the world poses a global health emergency. The serious outbreak position …
Anti-SARS-CoV-2 IgG and IgA antibodies in COVID-19 convalescent plasma do not enhance viral infection
NM Clark, SK Janaka, W Hartman, S Stramer… - PLoS …, 2022 - journals.plos.org
The novel coronavirus, SARS-CoV-2 that causes COVID-19 has resulted in the death of
nearly 4 million people within the last 18 months. While preventive vaccination, and …
nearly 4 million people within the last 18 months. While preventive vaccination, and …